Noven To Present At Banc of America Securities Specialty Pharmaceuticals Conference

-- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that company representatives are scheduled to present at the Banc of America Securities Specialty Pharmaceuticals Conference in Southampton, New York, on Thursday, July 28, 2005 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be accessible to the public at www.noven.com and a rebroadcast will be available thereafter at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Alina Bowman
Investor Relations Coordinator
Noven Pharmaceuticals, Inc.
305-253-1916